These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33834371)
1. Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism. Fang MC; Go AS; Prasad PA; Hsu JW; Fan D; Portugal C; Sung SH; Reynolds K J Thromb Thrombolysis; 2021 Nov; 52(4):1101-1109. PubMed ID: 33834371 [TBL] [Abstract][Full Text] [Related]
2. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study. Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Fang MC; Go AS; Prasad PA; Zhou HX; Parks AL; Fan D; Portugal C; Sung SH; Reynolds K Thromb Res; 2022 Aug; 216():97-102. PubMed ID: 35779378 [TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis. Dawwas GK; Dietrich E; Smith SM; Davis K; Park H Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247 [TBL] [Abstract][Full Text] [Related]
5. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region. Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203 [TBL] [Abstract][Full Text] [Related]
6. All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism. Roetker NS; Lutsey PL; Zakai NA; Alonso A; Adam TJ; MacLehose RF Thromb Haemost; 2018 Sep; 118(9):1637-1645. PubMed ID: 30103250 [TBL] [Abstract][Full Text] [Related]
7. Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants. Uppuluri EM; Burke KR; Haaf CM; Shapiro NL J Oncol Pharm Pract; 2019 Mar; 25(2):261-268. PubMed ID: 28942721 [TBL] [Abstract][Full Text] [Related]
8. Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration. Din N; Fan J; Schmitt S; Guo JD; Hlavacek P; Pundi K; Russ C; Emir B; Turakhia MP; Perino AC Clin Appl Thromb Hemost; 2023; 29():10760296231152474. PubMed ID: 36694957 [TBL] [Abstract][Full Text] [Related]
9. Assessing patient preferences for switching from warfarin to direct oral anticoagulants. Wright JN; Vazquez SR; Kim K; Jones AE; Witt DM J Thromb Thrombolysis; 2019 Nov; 48(4):596-602. PubMed ID: 31273515 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy. Patel SI; Cherington C; Scherber R; Barr K; McLemore R; Morisky DE; Cha S; Mookadam F; Shamoun F J Am Osteopath Assoc; 2017 Jan; 117(1):7-15. PubMed ID: 28055097 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of anticoagulation selection for acute venous thromboembolism. Badreldin H; Nichols H; Rimsans J; Carter D J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726 [TBL] [Abstract][Full Text] [Related]
13. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study. Badreldin H J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281 [TBL] [Abstract][Full Text] [Related]
14. Patient Satisfaction with Direct Oral Anticoagulants and Warfarin. Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ikeya Y; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A; Int Heart J; 2018 Nov; 59(6):1266-1274. PubMed ID: 30369576 [TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulant drugs for the management of venous thromboembolism. Thanavaro JL Nurse Pract; 2023 Jun; 48(6):27-35. PubMed ID: 37227313 [TBL] [Abstract][Full Text] [Related]
16. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants. Legnani C; Martinelli I; Palareti G; Ciavarella A; Poli D; Ageno W; Testa S; Mastroiacovo D; Ciammaichella M; Bucherini E; Mumoli N; Cosmi B PLoS One; 2019; 14(7):e0219751. PubMed ID: 31310608 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients. Lutsey PL; Horvath KJ; Fullam L; Moll S; Rooney MR; Cushman M; Zakai NA Thromb Haemost; 2018 Mar; 118(3):553-561. PubMed ID: 29448297 [TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban Versus Warfarin for Stroke Prevention and Venous Thromboembolism Treatment in Extreme Obesity and High Body Weight. Perales IJ; San Agustin K; DeAngelo J; Campbell AM Ann Pharmacother; 2020 Apr; 54(4):344-350. PubMed ID: 31672028 [No Abstract] [Full Text] [Related]
19. Practice patterns surrounding referral to a specialty venous thromboembolism (VTE) clinic: a retrospective review. Landry S; Ip S; Shiu J; Bungard TJ J Thromb Thrombolysis; 2022 Jan; 53(1):176-181. PubMed ID: 34146236 [TBL] [Abstract][Full Text] [Related]
20. Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study. Jun M; Lix LM; Durand M; Dahl M; Paterson JM; Dormuth CR; Ernst P; Yao S; Renoux C; Tamim H; Wu C; Mahmud SM; Hemmelgarn BR; BMJ; 2017 Oct; 359():j4323. PubMed ID: 29042362 [No Abstract] [Full Text] [Related] [Next] [New Search]